Passive Income
Biotech stocks are gaining attention as the global economy recovers from the pandemic. Government agencies and professional traders are investing in biotech companies to develop vaccines and boosters that can combat COVID-19. By tilting your portfolio toward biotech, you could reap significant profits. Additionally, there are cost-effective stocks under $20 that you can trade daily. Biotech companies are a subset of healthcare stocks focused on creating new drugs and treatments for various medical conditions, diseases, and viruses. The value and growth potential of a biotech firm hinge on the diseases it targets and the research it conducts. For example, a company working on breast cancer treatments, which affects nearly 300,000 new cases annually in the U.S., might be more valuable than one developing drugs for a rare disease like Ogilvie’s Syndrome, which impacts only 1%–3% of the population. Every new drug must undergo FDA approval. Companies spend years on development but may fail to get approved. Some drugs never reach the market despite extensive clinical trials. Conversely, if a biotech company gets a drug approved and demand is high, its stock value can double or triple overnight. An online broker can help you trade biotech stocks quickly and accurately. By opening an account, you gain access to professional tools like stock screens. You can apply custom filters, such as setting a price range, to find stocks under $10 within minutes. Explore these brokers to get started. Best for active and global traders. Interactive Brokers offers a comprehensive platform with access to over 150 global markets. You can trade options, futures, forex, and funds, often without commissions. While geared toward experienced traders, IBKR Lite makes it accessible for casual traders. Pros include smart routing for price improvement, fractional trading, low margin rates, and earning by lending shares. Cons: beginners may prefer more educational resources.
Best for leveraged trading. Plus500 is a CFD broker focusing on contracts for difference. Note that 81% of retail accounts lose money. CFDs are legal in many jurisdictions but not in the U.S. Plus500 charges no commission and profits from the spread. However, it’s not for beginners due to sparse educational materials and the high risk of CFDs. When selecting biotech stocks, consider the company’s pipeline, FDA approvals, and market potential. Look for firms with innovative treatments and strong research capabilities. Also, assess financial health and cash reserves to sustain long development cycles. Biotech investing requires patience. Clinical trials and FDA approvals take time. Avoid chasing quick gains; instead, focus on long-term potential. Diversify across multiple companies to mitigate risks. What are biotech stocks? Biotech stocks represent companies that develop drugs and treatments for medical conditions. How to trade biotech stocks? You can trade them through online brokers like Interactive Brokers or Plus500, using stock screens and filters. Are biotech stocks risky? Yes, due to FDA approval uncertainties and long development timelines, but they offer high reward potential.